本文发表于《临床试验竞技场》，重点探讨了澳大利亚与韩国如何解决放射性药物临床试验中的主要瓶颈问题。来自Novotech（诺为泰）的Stacy Lee阐述了如何通过高效的监管路径、多元化的供应网络以及多区域试验策略，减少试验启动延误情形，并为时间紧迫的放射性药物研究提供有力支持。
全球职业机会
Featured
Thought Leadership
文章
Featured media on Novotech’s leadership and impact.
博客
Expert insights and real-world perspectives.
白皮书
In-depth perspectives on forces shaping clinical research.
疾病报告
Tracking science and trends across therapeutic areas.
网络研讨会
Hear from experts shaping clinical development.
Podcasts
Conversations with leaders shaping drug development.
Featured
关于我们
关于我们
A global CRO and scientific partner advancing drug development.
社会影响
Our impact extends beyond trials, shaping healthier futures worldwide.
公司文化
A collaborative, science-driven approach.
奖项和荣誉
Recognized for excellence across the industry.
领导团队
Decades of clinical and scientific leadership.
招贤纳士
成长平台
A global clinical research leader with an award-winning culture.
活力职场
A culture that empowers growth, innovation, and impact.
当前职位
Explore career opportunities at Novotech.
员工福利与表彰制度
Benefits and recognition that support your success.
携手同行
Experts collaborating to advance clinical research.
Career Growth and Development
A commitment to your growth and development.
Clinical Graduate Program
Start your career in clinical research with Novotech.
2026/1/28